Certified by Founder Lodge
858 Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology.
858 was founded by a vetera
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 27 ,2024 | Series B | $50,000,000 |
New Enterprise Associates (NEA)
Logos Capital
Versant Ventures
Avidity Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
